NFE2L2 and triple-A syndrome: Additional studies in murine models found Itaconate, an anti-inflammatory mitochondrial metabolite produced by macrophages and monocytes, achieved protection against AAA formation via agonistic effects on the Nrf2 pathway and inhibition of the NLRP3 inflammasome [71].